Cross Country Healthcare, Inc. (CCRN)

Jul 21, 2026 - CCRN was delisted (reason: acquired by Knox Lane)

13.25

0.00 (0.00%)

Inactive · Last trade price on Jul 20, 2026

Cross Country Healthcare Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 17, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	428	265	586	796	991	1,055
Market Cap Growth	2.16%	-54.73%	-26.35%	-19.69%	-6.07%	216.63%
Enterprise Value	325	168	527	787	1,100	1,173
Last Close Price	-	8.10	18.16	22.64	26.57	27.76

Price Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 17, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	-	-	-	10.96	5.33	7.99
Forward PE	72.92	125.97	37.47	17.20	8.24	11.67
PS Ratio	0.43	0.25	0.44	0.39	0.35	0.63
PB Ratio	1.32	0.82	1.40	1.70	2.17	3.55
P/TBV Ratio	2.06	1.22	2.54	2.93	4.05	8.44
P/FCF Ratio	10.81	6.62	5.26	3.39	7.91	-
P/OCF Ratio	9.04	5.50	4.88	3.20	7.39	-
PEG Ratio	7.29	12.60	3.75	0.83	0.82	0.54

EV Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 17, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
EV/Sales Ratio	0.32	0.16	0.39	0.39	0.39	0.70
EV/EBITDA Ratio	22.99	9.09	31.39	5.88	3.79	7.59
EV/EBIT Ratio	-	66.36	-	6.79	3.96	8.08
EV/FCF Ratio	8.19	4.20	4.73	3.36	8.78	-

Financial Efficiency

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 17, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Debt / Equity Ratio	0.01	0.01	0.01	0.01	0.35	0.66
Debt / EBITDA Ratio	0.12	0.11	0.19	0.04	0.53	1.19
Debt / FCF Ratio	0.05	0.06	0.04	0.02	1.26	-
Net Debt / Equity Ratio	-0.33	-0.33	-0.19	-0.02	0.34	0.65
Net Debt / EBITDA Ratio	-7.34	-5.74	-4.64	-0.09	0.53	1.26
Net Debt / FCF Ratio	-2.61	-2.65	-0.70	-0.05	1.23	-2.10
Asset Turnover	1.95	2.03	2.12	2.48	3.34	3.08
Quick Ratio	3.20	3.61	2.63	2.56	2.42	2.48
Current Ratio	3.29	3.78	2.78	2.67	2.49	2.54
Return on Equity (ROE)	-26.98%	-25.57%	-3.28%	15.71%	49.28%	58.35%
Return on Assets (ROA)	-0.10%	0.31%	-0.07%	8.91%	20.68%	16.64%
Return on Invested Capital (ROIC)	-0.37%	0.91%	-0.18%	15.35%	37.04%	39.76%
Return on Capital Employed (ROCE)	-0.20%	0.70%	-0.20%	22.10%	41.10%	27.20%

Yields

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 17, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Earnings Yield	-23.04%	-35.74%	-2.48%	9.13%	18.77%	12.51%
FCF Yield	9.25%	15.11%	19.00%	29.47%	12.64%	-8.79%
Buyback Yield / Dilution	2.10%	2.91%	5.91%	5.49%	-0.39%	-3.61%

SEC Filings: 10-K · 10-Q